SC
BIIB icon

Steph & Co’s Biogen BIIB Stock Holding History

Steph & Co’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21K Sell
97
-48
-33% -$9.18K 0.01% 231
2026
Q1 		$26.6K Buy
145
+8
+6% +$1.47K 0.01% 234
2025
Q4 		$24.1K Buy
137
+58
+73% +$9.48K 0.01% 247
2025
Q3 		$11.1K Buy
79
+4
+5% +$541 ﹤0.01% 292
2025
Q2 		$9.42K Hold
75
– – ﹤0.01% 274
2025
Q1 		$10.3K Buy
75
+39
+108% +$5.58K ﹤0.01% 238
2024
Q4 		$5.5K Sell
36
-41
-53% -$6.92K ﹤0.01% 263
2024
Q3 		$14.9K Buy
77
+25
+48% +$5.23K ﹤0.01% 245
2024
Q2 		$12.1K Buy
52
+4
+8% +$869 ﹤0.01% 235
2024
Q1 		$10.3K Buy
+48
New +$11.2K ﹤0.01% 258
2022
Q2 		– Sell
-83
Closed -$17K – 243
2022
Q1 		$17K Hold
83
– – 0.01% 243
2021
Q4 		$20K Buy
+83
New +$21.3K 0.01% 258

Other funds holding BIIB

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return

Steph & Co's BIIB Position: Q2 2026 in Review

Steph & Co reduced its Biogen (BIIB) stake by 33% in Q2 2026, selling an estimated $9.18K and leaving 97 shares worth $21K. The position accounts for 0.01% of the portfolio, ranked #231.

Steph & Co first reported a position in BIIB in Q4 2021 and has held it in 12 quarters since. The position peaked at $26.6K in Q1 2026. 135 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Steph & Co held 97 shares of Biogen worth $21K as of Q2 2026.
  • Steph & Co sold 48 Biogen shares in Q2 2026, an estimated $9.18K.
  • Biogen made up 0.01% of Steph & Co's portfolio in Q2 2026, its #231 holding.
  • Steph & Co first reported a position in Biogen in Q4 2021 and has held it in 12 quarters since.
  • Steph & Co's Biogen position peaked at $26.6K in Q1 2026.
  • 135 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Steph & Co's 13F filing for Q2 2026, filed 16 Jul 2026.